Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 11:48 am Purchase | 2025-03-31 | 13G | Celldex Therapeutics, Inc. CLDX | Kynam Capital Management, LP | 6,500,000 9.790% | 1,435,793 (+28.35%) | Filing History |
| 2025-05-15 11:44 am Purchase | 2025-03-31 | 13G | Viridian Therapeutics, Inc. VRDN | Kynam Capital Management, LP | 4,700,000 5.760% | 4,700,000 (New Position) | Filing History |
| 2025-05-15 11:39 am Purchase | 2025-03-31 | 13G | Sutro Biopharma, Inc. STRO | Kynam Capital Management, LP | 5,441,447 6.440% | 5,441,447 (New Position) | Filing History |
| 2025-03-17 10:54 am Sale | 2025-03-11 | 13G | 2seventy bio, Inc. TSVT | Kynam Capital Management, LP | 0 0.000% | -5,953,825 (Position Closed) | Filing History |
| 2025-02-14 5:18 pm Purchase | 2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management, LP | 8,520,000 9.980% | 2,860,000 (+50.53%) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Kynam Capital Management, LP | 4,994,090 9.800% | 4,994,090 (New Position) | Filing History |
| 2025-02-14 5:16 pm Sale | 2024-12-31 | 13G | Dynavax Technologies Corporation DVAX | Kynam Capital Management, LP | 6,560,835 4.990% | -1,771,852 (-21.26%) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Kynam Capital Management, LP | 5,064,207 7.630% | 2,058,303 (+68.48%) | Filing History |
| 2024-11-14 12:29 pm Purchase | 2024-09-30 | 13G | Burning Rock Biotech Limited BNR | Kynam Capital Management, LP | 989,217 12.020% | 119,774 (+13.78%) | Filing History |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Kynam Capital Management, LP | 9,239,731 8.360% | 3,384,965 (+57.82%) | Filing History |
| 2024-11-14 12:18 pm Purchase | 2024-09-30 | 13G | Dynavax Technologies Corporation DVAX | Kynam Capital Management, LP | 8,332,687 6.340% | 8,332,687 (New Position) | Filing History |
| 2024-11-14 12:15 pm Sale | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management, LP | 1,576,549 2.490% | -2,073,790 (-56.81%) | Filing History |
| 2024-03-08 3:58 pm Purchase | 2024-02-29 | 13G | MorphoSys AG MOR | Kynam Capital Management, LP | 4,190,331 11.130% | 500,000 (+13.55%) | Filing History |
| 2024-02-14 12:53 pm Sale | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 0 0.000% | -2,025,234 (Position Closed) | Filing History |
| 2024-02-14 12:52 pm Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Kynam Capital Management, LP | 3,005,904 5.500% | 3,005,904 (New Position) | Filing History |
| 2024-02-14 12:51 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Kynam Capital Management, LP | 5,854,766 6.800% | 5,854,766 (New Position) | Filing History |
| 2024-02-14 12:50 pm Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management, LP | 5,660,000 6.670% | 5,660,000 (New Position) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management, LP | 3,650,339 8.220% | 2,241,241 (+159.06%) | Filing History |
| 2024-02-14 12:47 pm Purchase | 2023-12-31 | 13G | MorphoSys AG MOR | Kynam Capital Management, LP | 3,690,331 9.800% | 3,690,331 (New Position) | Filing History |
| 2024-02-14 12:45 pm Unchanged | 2023-12-31 | 13G | Burning Rock Biotech Limited BNR | Kynam Capital Management, LP | 869,443 10.190% | 0 (Unchanged) | Filing History |